Skip to main content

4 Result(s)

within Mubiao Liu Remove this filter

and

  1. No Access

    Article

    STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration

    Aberrant activation of STAT3 signal pathway promotes tumor progression in many solid tumor types, including cervical cancer and endometrial cancer. BBI608, the STAT3 inhibitor had been reported in previous stu...

    **g Chen, Shuting Huang, Huawen Li, Yun Li… in Clinical and Translational Oncology (2023)

  2. No Access

    Article

    Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China

    This study aimed to compare the 5-year overall survival (OS) and 5-year DFS disease-free survival (DFS) of abdominal radical hysterectomy (ARH) and radiochemotherapy (R-CT) for stage IIA2 (FIGO 2018) cervical ...

    Junshen He, Donglin Li, ** Shen… in International Journal of Clinical Oncology (2022)

  3. No Access

    Article

    Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study

    To compare oncological outcomes of laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) for low-risk cervical cancer.

    Zhiqiang Li, Chunlin Chen, ** Liu, Anwei Lu… in Archives of Gynecology and Obstetrics (2022)

  4. Article

    Open Access

    CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer

    Successful neoadjuvant chemotherapy (NACT) could improve the surgical resection rate and radical curability of patients with cervical cancer, but only a subset of patients benefits. Therefore, identifying pred...

    Yun Lin, Zhi Li, Mubiao Liu, Haiyan Ye, Jianhui He… in Archives of Gynecology and Obstetrics (2021)

    Download PDF (1074 KB) View Article